Cargando…
Corneal Collagen Cross-Linking in the Treatment of Progressive Keratoconus: A Randomized Controlled Contralateral Eye Study
BACKGROUND: To assess the short-term efficacy and safety of corneal collagen cross-linking (CXL) in preventing the progression of keratoconus (KCN). MATERIALS AND METHODS: This randomized controlled clinical trial enrolled 26 patients diagnosed with bilateral progressive KCN and were eligible for CX...
Autores principales: | Seyedian, Mohammad A., Aliakbari, Soheil, Miraftab, Mohammad, Hashemi, Hassan, Asgari, Soheila, Khabazkhoob, Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502179/ https://www.ncbi.nlm.nih.gov/pubmed/26180474 http://dx.doi.org/10.4103/0974-9233.159755 |
Ejemplares similares
-
Comparison of clinical results of two pharmaceutical products of riboflavin in corneal collagen cross-linking for keratoconus
por: Hashemi, Hassan, et al.
Publicado: (2014) -
Multipoint assessment of demarcation line depth after standard and accelerated cross-linking in central and inferior keratoconus
por: Asgari, Soheila, et al.
Publicado: (2018) -
Clinical results with two different pharmaceutical preparations of riboflavin in corneal cross-linking: an 18-month follow up
por: Hashemi, Hassan, et al.
Publicado: (2015) -
Mesopic Quality of Vision after Accelerated 18 mW/cm(2) Corneal Cross-linking: Mid-term Results
por: Hashemi, Hassan, et al.
Publicado: (2017) -
Refractive characteristics of keratoconus eyes with corneal Vogt's striae: A contralateral eye study
por: Rakhshandadi, Tahereh, et al.
Publicado: (2021)